Works matching AU Kitazaki, Takeshi

Results: 19

Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).

Published in:

Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640

By:

Nosaki, Kaname;
Yamanaka, Takeharu;
Hamada, Akinobu;
Shiraishi, Yoshimasa;
Harada, Taishi;
Himeji, Daisuke;
Kitazaki, Takeshi;
Ebi, Noriyuki;
Shimose, Takayuki;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Sugio, Kenji

Publication type:

Article

Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 1, p. 185, doi. 10.1007/s00520-014-2339-4

By:

Kitazaki, Takeshi;
Fukuda, Yuichi;
Fukahori, Susumu;
Oyanagi, Kazuhiko;
Soda, Hiroshi;
Nakamura, Yoichi;
Kohno, Shigeru

Publication type:

Article

A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4

By:

Ikeda, Takaya;
Fukuda, Minoru;
Nakamura, Yoichi;
Kinoshita, Akitoshi;
Senju, Hiroaki;
Nakano, Hirofumi;
Kitazaki, Takeshi;
Ogawara, Daiki;
Taniguchi, Hirokazu;
Motoshima, Kohei;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Shimada, Midori;
Nagashima, Seiji;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Article

BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.

Published in:

2006

By:

Nagashima, Seiji;
Soda, Hiroshi;
Oka, Mikio;
Kitazaki, Takeshi;
Shiozawa, Ken;
Nakamura, Yoichi;
Takemura, Masaaki;
Yabuuchi, Hikaru;
Fukuda, Minoru;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

journal article

Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.

Published in:

2009

By:

Ishimoto H;
Mukae H;
Sakamoto N;
Amenomori M;
Kitazaki T;
Imamura Y;
Fujita H;
Ishii H;
Nakayama S;
Yanagihara K;
Kohno S;
Ishimoto, Hiroshi;
Mukae, Hiroshi;
Sakamoto, Noriho;
Amenomori, Misato;
Kitazaki, Takeshi;
Imamura, Yoshifumi;
Fujita, Hanako;
Ishii, Hiroshi;
Nakayama, Seiko

Publication type:

journal article

Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.

Published in:

Respirology, 2007, v. 12, n. 1, p. 137, doi. 10.1111/j.1440-1843.2006.00966.x

By:

YAMAGUCHI, Hiroyuki;
SODA, Hiroshi;
KITAZAKI, Takeshi;
NAKANO, Hirofumi;
FUJINO, Satoru;
NAKAMURA, Yoichi;
KOHNO, Shigeru

Publication type:

Article

Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.

Published in:

International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528

By:

Ken Shiozawa;
Mikio Oka;
Hiroshi Soda;
Megumi Yoshikawa;
Yoji Ikegami;
Junji Tsurutani;
Katsumi Nakatomi;
Yoichi Nakamura;
Seiji Doi;
Takeshi Kitazaki;
Yohei Mizuta;
Kunihiko Murase;
Hisahiro Yoshida;
Douglas D. Ross;
Shigeru Kohno

Publication type:

Article

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.

Published in:

Thoracic Cancer, 2020, v. 11, n. 7, p. 1972, doi. 10.1111/1759-7714.13490

By:

Ikeda, Takaya;
Takemoto, Shinnosuke;
Senju, Hiroaki;
Gyotoku, Hiroshi;
Taniguchi, Hirokazu;
Shimada, Midori;
Dotsu, Yosuke;
Umeyama, Yasuhiro;
Tomono, Hiromi;
Kitazaki, Takeshi;
Fukuda, Masaaki;
Soda, Hiroshi;
Yamaguchi, Hiroyuki;
Fukuda, Minoru;
Mukae, Hiroshi

Publication type:

Article

Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

Published in:

Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279

By:

Takemoto, Shinnosuke;
Fukuda, Minoru;
Yamaguchi, Hiroyuki;
Ikeda, Takaya;
Akagi, Kazumasa;
Tomono, Hiromi;
Umeyama, Yasuhiro;
Dotsu, Yosuke;
Taniguchi, Hirokazu;
Gyotoku, Hiroshi;
Senju, Hiroaki;
Kitazaki, Takeshi;
Nakatomi, Katsumi;
Nagashima, Seiji;
Fukuda, Masaaki;
Kinoshita, Akitoshi;
Soda, Hiroshi;
Mukae, Hiroshi

Publication type:

Article

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.

Published in:

Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134

By:

Taniguchi, Hirokazu;
Yamaguchi, Hiroyuki;
Dotsu, Yosuke;
Shimada, Midori;
Gyotoku, Hiroshi;
Senju, Hiroaki;
Takemoto, Shinnosuke;
Kitazaki, Takeshi;
Fukuda, Masaaki;
Ogawara, Daiki;
Soda, Hiroshi;
Nakatomi, Katsumi;
Sugasaki, Nanae;
Kinoshita, Akitoshi;
Nagashima, Seiji;
Ikeda, Takaya;
Nakamura, Yoichi;
Sakamoto, Noriho;
Obase, Yasushi;
Fukuda, Minoru

Publication type:

Article

Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer.

Published in:

Thoracic Cancer, 2019, v. 10, n. 4, p. 872, doi. 10.1111/1759-7714.13017

By:

Mori, Mio;
Hayashi, Hideyuki;
Fukuda, Minoru;
Honda, Sumihisa;
Kitazaki, Takeshi;
Shigematsu, Kazuto;
Matsuyama, Naohiro;
Otsubo, Mayumi;
Nagayasu, Takeshi;
Hashisako, Mikiko;
Tabata, Kazuhiro;
Uetani, Masataka;
Ashizawa, Kazuto

Publication type:

Article

Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.

Published in:

Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958

By:

Takemoto, Shinnosuke;
Nakamura, Yoichi;
Gyoutoku, Hiroshi;
Senju, Hiroaki;
Ogawara, Daiki;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Kitazaki, Takeshi;
Nakano, Hirofumi;
Nakatomi, Katsumi;
Tomari, Shinya;
Sato, Shuntaro;
Nagashima, Seiji;
Fukuda, Minoru;
Mukae, Hiroshi

Publication type:

Article

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu ( LOGIK1004 A).

Published in:

Thoracic Cancer, 2017, v. 8, n. 1, p. 40, doi. 10.1111/1759-7714.12407

By:

Fukuda, Minoru;
Shimada, Midori;
Kitazaki, Takeshi;
Nagashima, Seiji;
Hashiguchi, Kohji;
Ebi, Noriyuki;
Takayama, Koichi;
Nakanishi, Yoichi;
Semba, Hiroshi;
Harada, Taishi;
Seto, Takashi;
Okamoto, Isamu;
Ichinose, Yukito;
Sugio, Kenji

Publication type:

Article

Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).

Published in:

Thoracic Cancer, 2016, v. 7, n. 4, p. 467, doi. 10.1111/1759-7714.12360

By:

Fukuda, Minoru;
Suetsugu, Takayuki;
Shimada, Midori;
Kitazaki, Takeshi;
Hashiguchi, Kohji;
Kishimoto, Junji;
Harada, Taishi;
Seto, Takashi;
Ebi, Noriyuki;
Takayama, Koichi;
Sugio, Kenji;
Semba, Hiroshi;
Nakanishi, Yoichi;
Ichinose, Yukito

Publication type:

Article

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837

By:

Takaya Ikeda;
Hiroyuki Yamaguchi;
Katsumi Nakatomi;
Hiroshi Mukae;
Midori Shimada;
Masaaki Fukuda;
Takeshi Kitazaki;
Kohji Hashiguchi;
Minoru Fukuda;
Kazuto Ashizawa

Publication type:

Article

A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Chemotherapy (0009-3157), 2016, v. 61, n. 2, p. 93, doi. 10.1159/000441486

By:

Kasai, Takashi;
Nakamura, Yoichi;
Fukuda, Minoru;
Kitazaki, Takeshi;
Nagashima, Seiji;
Takatani, Hiroshi;
Nakano, Hirofumi;
Nakatomi, Katsumi;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Tsukamoto, Kazuhiro;
Oka, Mikio;
Kohno, Shigeru

Publication type:

Article

Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 8, p. 1743, doi. 10.1007/s10096-021-04193-7

By:

Kaku, Norihito;
Hashiguchi, Kohji;
Akamatsu, Norihiko;
Wakigawa, Fumiko;
Matsuda, Junichi;
Komaru, Kenzo;
Nakao, Takumi;
Harada, Yosuke;
Hara, Atsuko;
Uno, Naoki;
Sakamoto, Kei;
Morinaga, Yoshitomo;
Kitazaki, Takeshi;
Hasegawa, Hiroo;
Miyazaki, Taiga;
Fukuda, Masaaki;
Izumikawa, Koichi;
Mukae, Hiroshi;
Yanagihara, Katsunori

Publication type:

Article

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08074-0

By:

Taniguchi, Hirokazu;
Yamada, Tadaaki;
Wang, Rong;
Tanimura, Keiko;
Adachi, Yuta;
Nishiyama, Akihiro;
Tanimoto, Azusa;
Takeuchi, Shinji;
Araujo, Luiz H.;
Boroni, Mariana;
Yoshimura, Akihiro;
Shiotsu, Shinsuke;
Matsumoto, Isao;
Watanabe, Satoshi;
Kikuchi, Toshiaki;
Miura, Satoru;
Tanaka, Hiroshi;
Kitazaki, Takeshi;
Yamaguchi, Hiroyuki;
Mukae, Hiroshi

Publication type:

Article

Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.

Published in:

2008

By:

Nakano, Hirofumi;
Nakamura, Yoichi;
Soda, Hiroshi;
Kamikatahira, Megumi;
Uchida, Kanako;
Takasu, Mineyo;
Kitazaki, Takeshi;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Yanagihara, Katsunori;
Kohno, Shigeru;
Tsukamoto, Kazuhiro

Publication type:

journal article